“TB Drugs and Hepatotoxicity” and “TB Case Presentations”
8:30 am – 9:00 am Registration and Sign-In
9:00 am – 9:05 am Welcome and Program Overview
Robert Miodovski, M.P.H.
Senior Health Educator, TB Control Program
9:05 am –10:05 am Part I – “TB Drugs and Hepatotoxicity” (1 hour C.M.E. credit)
Andrew Stolz, M.D.
Associate Professor of Medicine
Director, Molecular Biology Core, Research Center for Liver Diseases
LAC+USC Medical Center
10:05 am – 10:20 am Questions and Answers
10:20 am – 10:30 am Break
10:30 am – 11:30 am Part 2 – TB Case Presentations (1 hour C.M.E. credit)
Steven Hwang, M.D.
Facilitator, Assistant Director, TB Control Program
11:30 am Submission of Evaluations
This conference is designed to provide the clinician with a comprehensive overview of the problem of TB drug-induced hepatotoxicity, including its incidence, the basic science of liver physiology and theory of the mechanisms of drug-induced liver injury, and the approach to the clinical management of this common problem. Case presentations will follow the lecture.
- Describe the epidemiology of drug-induced hepatotoxicity in the treatment of TB disease and latent TB infection
- Explain the basic principles and theory of liver physiology and drug-induced hepatotoxicity
- Describe the recommended clinical approach to the patient with drug-induced hepatotoxicity while being treated for active TB disease and latent TB infection
- Explain how effective patient education and close patient-provider communication are essential in the early detection and timely management of TB drug induced hepatotoxicity
At the conclusion of TB Case Presentations, participants will be able to:
- Identify significant findings and changes in radiographs of patients with suspected or confirmed tuberculosis
- Apply the latest ATS/CDC recommendations regarding treatment.
- Identify at least one cultural or linguistic concern pertinent to the cases presented that is brought out during the group discussion.
Physicians: The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Nurses: Nurses receive a Certificate of attendance. This activity is designated for [ 2 ] AMA PRA Category 1 Credit(s)™ which is recognized by the California Board of Registered Nursing toward license renewal for registered nurses. (There is no CME provider number.)
Participants arriving more than 15 minutes late for a one-hour program or 30 minutes or more for a two-hour program will not be granted a CME certificate. There will be no partial credit granted for those who leave early.
Voluntary Request for Reasonable Accommodation (ADA): Individuals with special needs should contact the activity coordinator 10 working days in advance of the activity for assistance. Reference; ADA, July 26, 1990 (Public Law 101-366), Title 1, 11, 11 & IV
Your suggestions for future activities are welcome. For questions or further information, please contact:
Robert Miodovski, M.P.H., Sr. Health Educator, Tuberculosis Control Program
Tel. # 213-745-0801 Fax # 213-749-0926 E-mail address: firstname.lastname@example.org